# EDGAR Filing Document

**Accession Number:** 0001113229
**File Stem:** 0001145549-23-011861
**Filing Date:** 2023-2
**Character Count:** 15015
**Document Hash:** 9160f1d8ff873244415e444907a50374
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001145549-23-011861.hdr.sgml**: 20230228

**ACCESSION NUMBER**: 0001145549-23-011861

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20221231

**FILED AS OF DATE**: 20230228

**DATE AS OF CHANGE**: 20230227

**PERIOD START**: 20221231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** KINETICS PORTFOLIOS TRUST
- **CENTRAL INDEX KEY:** 0001113229
- **IRS NUMBER:** 223723753
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-09923
- **FILM NUMBER:** 23677098

**BUSINESS ADDRESS:**
- **STREET 1:** 470 PARK AVENUE SOUTH
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016
- **BUSINESS PHONE:** 9147036904

**MAIL ADDRESS:**
- **STREET 1:** 470 PARK AVENUE SOUTH
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10016

## Series and Classes Contracts Data

### Kinetics Medical Portfolio (Series ID: S000007854)

| Class ID   | Class Name                 | Ticker Symbol   |
|:---|:---|:---|
| C000021363 | Kinetics Medical Portfolio |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Kinetics Portfolios Trust

- **b. Investment Company Act file number:** 811-09923

- **c. CIK number of Registrant:** 0001113229

- **d. LEI of Registrant:** 254900ZCVXM48Q9D2T43

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 470 Park Avenue South

  - **City:** New York

  - **State:** NY

  - **Foreign country:** US

  - **Zip / Postal Code:** 10016

  - **Telephone number:** 800-930-3828

**Item A.2. Information about the Series.**

- **a. Name of Series:** Kinetics Medical Portfolio

- **b. EDGAR series identifier (if any):** S000007854

- **c. LEI of Series:** 254900PXE2K7ODL7PG52

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2022-12-31

- **b. Date as of which information is reported:** 2022-12-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $19273527.49

**Total Liabilities:** $33558.94

**Net Assets:** $19239968.55

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000021363 | 0.90%                | 7.34%                | 4.14%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $0.00                    | $1507753.11                                |
| Month 2  | $33211.59                | $1116530.44                                |
| Month 3  | $160016.41               | $-748928.77                                |

### Schedule of Portfolio Investments

| Name                           | Title                                 | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| AbbVie Inc                     | AbbVie Inc                            | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |     10000 | NS      | $1616100.00   | 8.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Agenus Inc                     | Agenus Inc                            | CUSIP: 00847G705<br>LEI: 529900NDQQGU5H4UJK81 | Long             | EC               | CORP              | US        |       148 | NS      | $355.20       | 0.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Alnylam Pharmaceuticals Inc    | Alnylam Pharmaceuticals Inc           | CUSIP: 02043Q107<br>LEI: 529900S3ZI14OWRJII50 | Long             | EC               | CORP              | US        |      3000 | NS      | $712950.00    | 3.71%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                             | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |      4000 | NS      | $1050560.00   | 5.46%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                       | CUSIP: 046353108<br>LEI: PY6ZZQWO2IZFZC3IOL08 | Long             | EC               | CORP              | GB        |     13000 | NS      | $881400.00    | 4.58%             |  |  |  | No            |                  1 | On Loan: No      |
| Biogen Inc                     | Biogen Inc                            | CUSIP: 09062X103<br>LEI: W8J5WZB5IY3K0NDQT671 | Long             | EC               | CORP              | US        |      3750 | NS      | $1038450.00   | 5.40%             |  |  |  | No            |                  1 | On Loan: No      |
| Bluebird Bio Inc               | Bluebird Bio Inc                      | CUSIP: 09609G100<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      3000 | NS      | $20760.00     | 0.11%             |  |  |  | No            |                  1 | On Loan: No      |
| Bristol-Myers Squibb Co        | Bristol-Myers Squibb Co               | CUSIP: 110122108<br>LEI: HLYYNH7UQUORYSJQCN42 | Long             | EC               | CORP              | US        |     23500 | NS      | $1690825.00   | 8.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Editas Medicine Inc            | Editas Medicine Inc                   | CUSIP: 28106W103<br>LEI: 5299000AON4Q9NT2JE42 | Long             | EC               | CORP              | US        |      8000 | NS      | $70960.00     | 0.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Galectin Therapeutics Inc      | Galectin Therapeutics Inc             | CUSIP: 363225202<br>LEI: 5299004HFYSAZM2ALW85 | Long             | EC               | CORP              | US        |     26000 | NS      | $29380.00     | 0.15%             |  |  |  | No            |                  1 | On Loan: No      |
| General Electric Co            | General Electric Co                   | CUSIP: 369604301<br>LEI: 3C7474T6CDKPR9K6YT90 | Long             | EC               | CORP              | US        |      3000 | NS      | $251370.00    | 1.31%             |  |  |  | No            |                  1 | On Loan: No      |
| Gilead Sciences Inc            | Gilead Sciences Inc                   | CUSIP: 375558103<br>LEI: 549300WTZWR07K8MNV44 | Long             | EC               | CORP              | US        |      9000 | NS      | $772650.00    | 4.02%             |  |  |  | No            |                  1 | On Loan: No      |
| GSK PLC                        | GSK PLC                               | CUSIP: 37733W204<br>LEI: 5493000HZTVUYLO1D793 | Long             | EC               | CORP              | GB        |     11738 | NS      | $412473.32    | 2.14%             |  |  |  | No            |                  1 | On Loan: No      |
| Haleon PLC                     | Haleon PLC                            | CUSIP: 405552100<br>LEI: 549300PSB3WWEODCUP19 | Long             | EC               | CORP              | GB        |     14673 | NS      | $117384.00    | 0.61%             |  |  |  | No            |                  1 | On Loan: No      |
| Immune Pharmaceuticals Inc     | Immune Pharmaceuticals Inc            | CUSIP: 45254C200<br>LEI: 549300GB18Q03BWVIM19 | Long             | EC               | CORP              | US        |         1 | NS      | $0.00         | 0.00%             |  |  |  | No            |                  3 | On Loan: No      |
| Intellia Therapeutics Inc      | Intellia Therapeutics Inc             | CUSIP: 45826J105<br>LEI: 5493002T5BCPE5DZC723 | Long             | EC               | CORP              | US        |     10000 | NS      | $348900.00    | 1.81%             |  |  |  | No            |                  1 | On Loan: No      |
| Ionis Pharmaceuticals Inc      | Ionis Pharmaceuticals Inc             | CUSIP: 462222100<br>LEI: 549300SI4ZGLG0BLUZ92 | Long             | EC               | CORP              | US        |      8000 | NS      | $302160.00    | 1.57%             |  |  |  | No            |                  1 | On Loan: No      |
| Johnson & Johnson              | Johnson & Johnson                     | CUSIP: 478160104<br>LEI: 549300G0CFPGEF6X2043 | Long             | EC               | CORP              | US        |      7000 | NS      | $1236550.00   | 6.43%             |  |  |  | No            |                  1 | On Loan: No      |
| Ligand Pharmaceuticals Inc     | Ligand Pharmaceuticals Inc            | CUSIP: 53220K173<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     44000 | NS      | $5720.00      | 0.03%             |  |  |  | No            |                  2 | On Loan: No      |
| Ligand Pharmaceuticals Inc     | Ligand Pharmaceuticals Inc            | CUSIP: 53220K181<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     44000 | NS      | $220.00       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Ligand Pharmaceuticals Inc     | Ligand Pharmaceuticals Inc            | CUSIP: 53220K199<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     44000 | NS      | $132.00       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Ligand Pharmaceuticals Inc     | Ligand Pharmaceuticals Inc            | CUSIP: 53220K215<br>LEI: 5493008K7TB0IKP37H79 | Long             | EC               | CORP              | US        |     44000 | NS      | $264.00       | 0.00%             |  |  |  | No            |                  2 | On Loan: No      |
| Eli Lilly & Co                 | Eli Lilly & Co                        | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |      5000 | NS      | $1829200.00   | 9.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                 | Merck & Co Inc                        | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |     14000 | NS      | $1553300.00   | 8.07%             |  |  |  | No            |                  1 | On Loan: No      |
| Novartis AG                    | Novartis AG                           | CUSIP: 66987V109<br>LEI: 5493007HIVTX6SY6XD66 | Long             | EC               | CORP              | CH        |     14000 | NS      | $1270080.00   | 6.60%             |  |  |  | No            |                  1 | On Loan: No      |
| Organon & Co                   | Organon & Co                          | CUSIP: 68622V106<br>LEI: 549300AMCKY57OK2CO56 | Long             | EC               | CORP              | US        |      8400 | NS      | $234612.00    | 1.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Pacific Biosciences of Califor | Pacific Biosciences of California Inc | CUSIP: 69404D108<br>LEI: 529900F1BWRE1M0KZN89 | Long             | EC               | CORP              | US        |     12000 | NS      | $98160.00     | 0.51%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                     | Pfizer Inc                            | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |     30000 | NS      | $1537200.00   | 7.99%             |  |  |  | No            |                  1 | On Loan: No      |
| Salarius Pharmaceuticals Inc   | Salarius Pharmaceuticals Inc          | CUSIP: 79400X305<br>LEI: 549300CLUMLZXIHU7X22 | Long             | EC               | CORP              | US        |      2400 | NS      | $3672.00      | 0.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Sanofi                         | Sanofi                                | CUSIP: 80105N105<br>LEI: 549300E9PC51EN656011 | Long             | EC               | CORP              | FR        |     13000 | NS      | $629590.00    | 3.27%             |  |  |  | No            |                  1 | On Loan: No      |
| US BANK MMDA - USBGFS 7        | US BANK MMDA - USBGFS 7               | CUSIP: N/A<br>LEI: N/A                        | Long             | STIV             | RF                | US        |    575266 | NS      | $575265.80    | 2.99%             |  |  |  | No            |                  1 | On Loan: No      |
| 2seventy bio Inc               | 2seventy bio Inc                      | CUSIP: 901384107<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1000 | NS      | $9370.00      | 0.05%             |  |  |  | No            |                  1 | On Loan: No      |
| Vanda Pharmaceuticals Inc      | Vanda Pharmaceuticals Inc             | CUSIP: 921659108<br>LEI: 529900AY8VOOQBKJ0O70 | Long             | EC               | CORP              | US        |      7000 | NS      | $51730.00     | 0.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Viatris Inc                    | Viatris Inc                           | CUSIP: 92556V106<br>LEI: 254900ZZTSW7NL773X71 | Long             | EC               | CORP              | US        |      3722 | NS      | $41425.86     | 0.22%             |  |  |  | No            |                  1 | On Loan: No      |
| Alkermes PLC                   | Alkermes PLC                          | CUSIP: N/A<br>LEI: N/A                        | Long             | EC               | CORP              | IE        |     22000 | NS      | $574860.00    | 2.99%             |  |  |  | No            |                  1 | On Loan: No      |
| CRISPR Therapeutics AG         | CRISPR Therapeutics AG                | CUSIP: N/A<br>LEI: 506700O6IRRIQLT3W370       | Long             | EC               | CORP              | CH        |      6000 | NS      | $243900.00    | 1.27%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2023-02-24

**Name of Applicant:** Kinetics Portfolios Trust

**Signature:** /s/ Jay Kesslen

**Name of Signer:** Kinetics Portfolios Trust

**Title:** Vice President